期刊文献+

苯磺酸氨氯地平或非洛地平联合吲达帕胺降压疗效对比分析 被引量:7

下载PDF
导出
摘要 目的观察比较使用苯磺酸氨氯地平或非洛地平联合吲达帕胺治疗高血压的疗效。方法对无锡市广瑞路社区卫生服务中心2008、2009年收治高血压患者分为两组,苯磺酸氨氯地平加吲达帕胺为对照组,非洛地平加吲达帕胺为观察组,比较两组治疗前后的血压变化。结果对照组降压有效率为93.3%,观察组降压有效率为90.2%,两组之间差异无统计学意义(P>0.05)。结论两种治疗方法均能获得相似的降压效果,苯磺酸氨氯地平和非洛地平都是治疗2型糖尿病的有效药物。
作者 余栋华
出处 《中国现代药物应用》 2010年第15期125-126,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献3

二级参考文献15

  • 1吴桂贤,吴兆苏,王薇,刘静,孙佳艺,刘军,赵冬.1992—2002年北京一组队列人群心血管病危险因素变化趋势研究[J].中华心血管病杂志,2005,33(8):748-753. 被引量:53
  • 2王薇,赵冬,刘静,曾哲淳,孙佳艺,刘军,秦兰萍,吴兆苏.中国35~64岁人群胆固醇水平与10年心血管病发病危险的前瞻性研究[J].中华心血管病杂志,2006,34(2):169-173. 被引量:133
  • 3Pedoe HT,Kuulasmaa K,Amouyel P,et al.Myocardial infarction and coronary deaths in the World Health Organization MONICA Project.Registration procedures,event rates,and case-fatality rates in 38 populations from 21 countries in four continents.Circulation,1994,90:583-612.
  • 4Rodriguez BL,D′Agostino R,Abbott RD,et al.Risk of hospitalized stroke in men enrolled in the Honolulu Heart Program and the Framingham Study:A comparison of incidence and risk factor effects.Stroke,2002,33:230-237.
  • 5Critchley J,Liu J,Zhao D,et al.Explaining the increase in coronary heart disease mortality in Beijing 1984 and 1999.Circulation,2004,110:1236-1244.
  • 6Jood K,Jern C,Wilhelmsen L,et al.Body mass index in mid-life is associated with a first stroke in men:a prospective population study over 28 years.Stroke,2004,35:2764-2769.
  • 7Wilson Peter WF,Agostino RBD,Levy D,et al.Prediction of coronary heart disease using risk factor categories (Framingham).Circulation,1998,97:1837-1847.
  • 8Kannel WB,D′Agostino RB,Sullivan L,et al.Concept and usefulness of cardiovascular risk profiles.Am Heart J,2004,148:16-26.
  • 9Pearson TA,Blair SN,Daniels SR,et al.AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke:2002 Update:Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases.Circulation,2002,106:388-391.
  • 10Grundy SM,Pasternak R,Greenland P,et al.Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations:A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology.Circulation,1999,100:1481-1492.

共引文献126

同被引文献47

  • 1韩友萍.替米沙坦与苯磺酸左旋氨氯地平联用治疗原发性高血压的疗效观察[J].实用心脑肺血管病杂志,2010,18(12):1802-1803. 被引量:10
  • 2张鑫,高霞.咪达普利联合吲达帕胺治疗高血压病逆转左室肥厚的疗效观察[J].现代中西医结合杂志,2006,15(14):1923-1923. 被引量:3
  • 3Kearney PM,Whelton M, Reynolds K, et al. Global burden of hy- pertension: analysis of worldwide data [ J ]. Lancet, 2005, 365 (9455) :217 - 223.
  • 4Campbell DB,Phllips EM. Short Term effects and urinary excretion of the new diuretic, indapamie, in normal subjects [ J ]. Eur J Clin Pharmacol, 1974,7 ( 6 ) :407 - 414.
  • 5Franz IW, Lohmann FW. The influence of a combined diurectic-be- ta-rcceptorblocker therapy on elevated exercise blood pressure,erqo- metric investigations in hypertensive patients (author transl) [ J]. Med kin,1979,74(ll) :396 -400.
  • 6王淑霞,王栋,韩庆玺.老年高血压治疗体会[J].中外健康文摘,2012,9(7):24-25.
  • 7Martinez MA, Sancho T, Garcia P, et al. Home blood pressure in poorly controlled hypertension:relationship with ambulatory blood pressure and organ damage [ J ]. Blood Press Mon, 2006, 11 ( 4 ) : 207 - 213.
  • 8Dorval JF, Anderson T, Buithieu J, et al. Reaching recommended lipid and blood pressure targets with amlodipine/atorvastatin combi- nation in patients with coronary heart disease[J]. Am J Cardiol,2005,95(2):249 -253.
  • 9Hond ED, Celis H, Fagard R,et al. Self-measured versus ambulatory blood pressure in the diagnosis of hypertension [ J ]. J Hypertens, 2003,21 (4) :717 -722.
  • 10Neglia D, Fommei E, Varela-Carver A,et al. Perindopril and inda- pamie reverse coronary microvascular remodeling and improve flow in arterial hypertension [ J ]. J Hypertens,2011,29 ( 2 ) : 364 - 372.

引证文献7

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部